Cargando…
Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409094/ https://www.ncbi.nlm.nih.gov/pubmed/34485659 http://dx.doi.org/10.1016/j.jemep.2021.100710 |